The extracts of six medicinal plants namely Terminalia chebula fruits, Commiphora myrrha gum, Solenostemma argel leaves, Rutagraveolens aerial parts, Cistanche phelypaea aerial parts and Striga hermonthica stem used in traditional Sudanese medicine for the treatment of gastrointestinal tract infections were selected to evaluate their potential antibacterial activity. The antibacterial activity of methanolic and aqueous extracts of these plants were determined by agar diffusion technique in vitro against 20 clinical isolates (2 were Salmonella typhi, 5 Proteus mirabilis, 4 Escherichia coli, 5 Pseudomonas aeruginosa, 3 Staphylococcus aureus, one was Salmonella paratyphi B) and 5 standard bacterial strains (Staphylococcus aureus ATCC 25923), Bacillus subtilis (NCTC 8236), Escherichia coli (ATCC 25922), Salmonella typhi (ATCC1319106) and Klebsiella pneumoniae (ATCC 35657) at a concentration of 100 mg/ml. Of all plants methanolic and aqueous extracts of T. chebula fruits were the most active with clinical isolates and standard bacterial strains showed relatively high antibacterial activity against most of the tested microorganisms with the diameter of inhibition zones ranging between 20 and 24 mm, whereas the methanolic extract of Commiphora myrrha showed high antibacterial activity against Proteus mirabilis and Escherichia coli clinical isolate (1Z = 20 mm). Solenostemma argel leaves was found moderately effective against S. aureus (ATCC 25923 ((1Z = 18 mm) but did not show any activity against all tested clinical isolates bacteria. Most susceptible Gram-negative clinical Isolates bacteria were Escherichia coli and Proteus mirabilis. Most susceptible Gram negative standard bacteria were Bacillus subtilis (NCTC 8236) and Escherichia coli (ATCC 25922) and least susceptible Gram negative bacterium was Klebsiella pneumoniae (ATCC35657). In Gram positive standard bacteria, most susceptible was S. aureus (ATCC 25923). Antibiotics was used as standards drug for antibacterial assay. The present study reveals potential use of these plants for developing new antibacterial compounds against gastrointestinal tract pathogenic microorganisms.
Introduction
The use of medicinal plants to treat human diseases has its roots in pre-historical times. Despite of the modern advances achieved in the field of synthetic chemistry, the most efficient drugs available had derived directly or indirectly, related from plant kingdom. Indigenous communities had long used plant extracts to treat illness. Many of these extracts had shown effective action with new bioactive compounds being extracted and screened every year. These extracts had also proven to be good sources of therapeutic agents to the treatment of infectious diseases [1] [2] . Sudan throughout its long history has accumulated a rich body of empirical knowledge of the use of medicinal plants for the treatment of various diseases.
The antimicrobial activity of Terminalia chebula against a variety of bacterial and fungal strains has been well investigated by several researchers [3] - [20] .
The antibacterial and fungal activities of Solenostemma argel [21] [22], Comiphora myrrha [24] - [27] and Cistanche phelypaea [28] have been received considerable.
The main aim of this study is that due to increasing concerns about the development of antimicrobial resistance among pathogenic bacteria, so alternative strategies are sought that do not use antibiotics to reduce pathogenic bacteria from foods and patients.
Materials and Methods
The fruits of Terminalia chebula, Commiphora myrrha gum, Cistanche phelypaea root, Striga hermonthica stem, and Solenostemma argel leaves were purchased from Omdurman market on the basis of undocumented reports for antibacterial activity. The plants were identified by one author Prof. Hatil H. Elkamali and by comparison with herbarium of the Department of the Botany Department, Faculty of Science and Technology, Omdurman Islamic University. The dried plants were pulverized with a mechanical grinder.
Two hundred gramsofall plants was macerated separately with 50% methanol (MeOH) in a conical flask for 24 hours. Mother liquor (crude MeOH extract) was filtered and evaporated to dryness. The dry crude extract was sterilized. All extracts were stored dry in sterilized containers at room temperature until used for antibacterial testing. At the time of testing, the extracts were prepared at a concentration of 100 mg/ ml in methanol.
Dried plant material (100 g) was ground to a fine powder. It was macerated with distilled water (1 L), and left for 24 hours at room temperature. The mother liquor was filtered. The filtrate, thus obtained was evaporated to complete dryness at room temperature. The residue thus obtained was aqueous plant extract.
The antibacterial activity was tested by well-agar diffusion method [29] [30]. 250 ml of sterilized nutrient agar was used for testing. The inoculum size of each test organism was adjusted to suspension of 10 6 cells. 2 ml of 24 hours old culture of bacteria were added to 250 ml of melted cooled test agar and after through mixing, approximately 20 ml of this seeded agar were poured into 10 cm diameter presterilized petri dishes and allowed to solidify. Four wells (10 mm in diameter) were bored in the agar using a sterile cork borer and the agar discs were removed. 0.1 ml aliquots of the prepared extract was placed into a well with a pipette and the plate was held for 2 hours at room temperature for diffusion of extract into agar. Subsequently, the plate was incubated at 37˚C for 24 hours. After incubation, the diameter of the zones of inhibition were measured to the nearest mm.
The minimum inhibitory concentration (MIC) was determined by a modification of the agar diffusion method [29] . A two-fold serial dilution of each extract was prepared in methanol to achieve a decreasing range of extract concentrations from 100 mg/ml to approximately 3.125 mg/ml. A 0.1 ml sample of each dilution was introduced into duplicate wells in a nutrient agar plate already seeded with bacterial cells as described above. Incubation was at 37˚C for 24 hours. The lowest concentration of extract showing a zone of inhibition was taken as the MIC.
Multidisc for antimicrobial susceptibility testing from Axiom laboratories, New Delhi, India for were used as 
Results and Discussion
Some bacterial strains showed a fairly high degree of sensitivity to the methanolic extracts of T. chebula fruits such as P. mirabilis isolates no. (3, 4) , E. coli isolates no. (5, 10), P. aeruginosa (7, 8, 13) Table 1) .
The antibacterial activity related to known antibiotics was calculated. The results are shown in Table 2 .
Ceftizoxime was found effective against P. mirabilis isolate no. (2) and P. aeruginosa isolate no. (13) at concentration 30 mcg, and moderate effectively was observed against P. aeruginosa isolate no. (15) and E. coli (ATCC 25922). Cefotaxime (CF) showed promising result against P. mirabilis isolate no. (4) at concentration 30 mcg ( Table 2) . It was showed no antibacterial activity against S. aureus (ATCC 25923) and S. typhi (ATCC-1319106). Ciprofloxacin (CP) showed a fairly high degree of sensitivity to E. coli isolate no. (6), P. aeruginosa isolate no. (7), S. typhi B isolate no. (7) and B. subtilis (NCTC 8236) at concentration 5 mcg, and demonstrated antibacterial activity against E.coli (ATCC 25922), K. pneumoniae (ATCC 35657) ( Table 3) .
Tetracycline (TE) showed good results against E. coli isolate no. (6) and E. coli (ATCC 25922) at concentration 30 mcg. Amikacin (AK) showed high antibacterial activity against E. coli isolate no. (10) at concentration 30 mcg, and moderate effectively was observed against E. coli isolate no. (5), P. aeruginosa isolate no. (7) and E. coli (ATCC 25922). It was showed no antibacterial activity against S. aureus (ATCC 25923) and S. typhi (ATCC1319106). S. aureus (ATCC 25923), B. subtilis (NCTC 8236), E. coli (ATCC 25922), S. typhi (ATCC-1319106) and K. pneumoniae (ATCC 35657) was found to be co-trimoxazole resistant. Co-Trimoxazole was found effective against S. typhi B isolate no. (17) at concentration 25 mcg and showed good results against E. coli isolate no. (9), S. aureus (14) and P. aeruginosa isolate no. (15) .
Piperacillin/Tazobactam (TZP) showed good results against E. coli isolate no. (6) at concentration 100/10 mcg, and found to be ineffective against all standard bacteria except B. subtilis (NCTC 8236). Chloramphenicol (CH) showed promising result against B. subtilis (NCTC 8236) at concentration 30 mcg, and moderate effectively was observed against E. coli isolate no. (9) S. aureus isolate no. (14), P. aeruginosa isolate no. (15) and P. mirabilis isolate no. (19) , whereas S. aureus (ATCC 25923), E. coli (ATCC 25922), S. typhi (ATCC1319106) and K. pneumoniae (ATCC 35657) was found to be chloramphenicol resistant.
Methanolic extracts of T. chebula fruits showed high antibacterial activity against clinical isolates and moderate to some of standard bacteria, about 60% of P. mirabilis revealed promising sensitivity, 50% of S. aureus clinical isolates showed good activity and surprise sensitivity of standard S. aureus (ATCC 25923) has become resistant to all known antibiotics has posed a threat already for a number of years. It has thus become apparent that new antimicrobial agents will continue to select for resistant strains from the pool of bacteria which continuously undergo genetic change [31] . T. chebula can serve as a starting point in future drug development aimed at the production of a new safe, effective and bio-accessible therapeutic agent.
The polar extracts of T. chebula fruits, (methanol) exhibited promising antibacterial activity against most Pro- The aqueous extracts of all plants except T. chebula do not possess significant antibacterial activity both against standard and clinical strains. These results account for why the Sudanese people do not frequently use these plants as a remedy, but may possess anti-inflammatory activities.
T. chebula can serve as a starting point in future drug development aimed at the production of a new safe, effective and bio-accessible therapeutic agent. Plants were able to develop new, faster and natural antimicrobials and then man-made remedies, and that is explaining why plants succeed in its fighting against microbes since millions of years while human failed [35] .
Methanolic extracts of Commiphora myrrha gumshowed potent antibacterial activity against clinical isolates P. mirabilis isolate no. (3) and E. coli isolate no. (6) . Furanosesquiterpenes, the active compounds in C. myrrh essential oil, possessed a significant antiseptic property, also be the characteristic components of pharmaceutical myrrh [26] [36] . All standard bacteria showed resistant to methanolic and aqueous extracts. Most of standard bacteria showed antibiotic-resistant. The reason for different sensitivity between Gram-positive and Gram negative bacteria could be ascribed to the morphological differences between these microorganisms. Gram-negative bacteria have an outer phospholipids membrane carrying the structural lipopolysaccharide components. This makes the cell wall impermeable to lipophilic solutes, while porins constitute a selective barrier to the hydrophilic solutes. The Gram-positive bacteria should be more susceptible since they have only an outer peptidoglycan layer which is not an effective permeability barrier [37] .
Antibiotic-resistant S. aureus (ATCC 25923) showed promising activity against S. argel leaves. Staphylococcal disease has been a perennial problem in the hospital environment since the beginning of the antibiotic era, hospital strains of S. aureus were usually resistant to a variety of different antibiotics. A few strains were resistant to all clinically useful antibiotics except vancomycin, and vancomycin-resistant strains were increasingly reported [38] .
Methanolic extracts of T. chebula fruits showed high antibacterial activity against E. coli and S. aureus which showed antibiotic-resistant to most antibiotic and similarly to amikacin, and S. aureus (12) showed antibioticresistant to most antibiotic and similarly to gatifloxacin. These plants could serve as useful sources for new antimicrobial agents and the fruits extracts of T. chebula may be used as remedy against various diseases without any side effects [39] .
Staphylococcus has changed from the status of a non-pathogen to that of an opportunistic pathogen. Although once regarded as an important opportunistic innocuous member of the normal skin flora, Staphylococcus now recognized as an important opportunistic pathogen. It is routinely found on the skin and in the hospital environment, with prevalence on the skin surface of 85% -100%. Staphylococcus was found excessively on damaged skin surface in normal persons [40] .
Of the all S. aureus isolates, only one was more sensitive to themethanolic extract of T. chebula fruits and effective more than Gram negative antibiotics, also T. chebula showed high activity against standard S. aureus (ATCC 25923) were it showed antibiotic-resistant ( Table 1) . Study of the synergistic interaction of active phyto-compounds with antibiotics is required to exploit these potential plant extracts in the combination therapy of infectious diseases caused by multi drug-resistant organisms [41] .
75% of P. aeruginosa showed high sensitivity toward methanolic extract, Escherichia coli which showed antibiotic-resistant to most antibiotic and similarly to amikacin. In the last decades, prevalence and outbreaks of the multi-drug resistant bacterial strains has been increasingly documented throughout the world. At present most clinical isolates of E. coli areconsidered as highly resistant to most commercially known antibiotics [35] . Out of the 20 clinical isolates from the infected stool, 2 were S. typhi, 5 P. mirabilis, 4 E. coli, 5 P. aeruginosa, 3 S. aureus, one was S typhi B. This is in line with fact that P. mirabilis, E. coli and P. aeruginosa are the most commonly taxa encountered contaminants of stool in foods. All bacterial species were found to be resistant against aqueous extracts of all studied plant species (except T. chebula). Compared to the most reference antibiotics, the spectrum of antibacterial activity of T.chebula was found to be clearly superior ( Table 4 & Table 5 ).
The phytochemistry of Terminalia chebula, Solenostemma argel, Commiphora myrrha, Rutagraveolens and Cistanche phelypaea have been received considerable interest [42] - [46] . Hexane and dichloromethane extracts 7
March 2016 | Volume 3 | e2488 of Terminalia chebula have shown more antibacterial compounds than acetone extract indicating the non-polar character of the antibacterial compounds [42] . Nine flavonoidal compounds were extracted from stem aqueous extract of Solenostemma argel. The kaempferol was more effective as antibacterial agent [43] . Three compounds known for their antibacterial effects of Commiphora myrrha: 2-fluorodiphenylmethane, tribenzo-1, 2,3,4,5,6anthracene and 2-bromo-1-(4-bromophenyl)ethanone [44] . Orlanda and Nascimento mention that Rutagraveolens could be used as a natural source for antibacterial compounds and possible applications in the pharmaceutical industry [45] . Several phenylethanoid glycosides isolated from Cistanche spp. showed an antibacterial activity against Staphylococcus aureus [46] . Therefore, the results obtained in our research work match the results obtained by other researches.
Conclusions
The most antibacterial active plant was T. chebula fruits. Of all extracts the methanolic and aqueous extracts of T. chebula fruits was the most active, whereas, the aqueous extracts of all plants do not possess significant antibacterial activity both against standard and clinical strains. Methanol extracts of C. myrrha gumand T. chebula fruits showed high antibacterial activity against P. mirabilis, E. coli, P. aeruginosa, S. aureus, S. typhi and S. typhi B clinical isolates, whereas the aqueous extracts of all plants were found to be ineffective against all tested bacteria Gram-positive and Gram-negative T. chebula fruitswhich showed moderate effect against P. mirabilis, E. coli, P. aeruginosa S. typhi and S. typhi B.
Some standard bacterial species showed a fairly high degree of sensitivity to the methanolic extracts of T. chebula fruits against B. subtilis (NCTC 8236) and S. aureus (ATCC 25923), whereas the aqueous extracts of all plants were found to be ineffective against all tested bacteria except T. chebula fruits showed moderate potency against B. subtilis (NCTC 8236).
The antibacterial screening of the different extracts (methanol and aqueous) was performed against standard and clinically isolated bacterial strains. The highest antibacterial activity was found in methanolic extracts, the lowest one was found in aqueous extract.
